Pages that link to "Q36516410"
Jump to navigation
Jump to search
The following pages link to Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer (Q36516410):
Displaying 50 items.
- Validation of the effects of TGF-β1 on tumor recurrence and prognosis through tumor retrieval and cell mechanical properties (Q21246016) (← links)
- Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk. (Q22000749) (← links)
- Hallmarks of Cancer: The Next Generation (Q22252312) (← links)
- MDSC and TGFβ are required for facilitation of tumor growth in the lungs of mice exposed to carbon nanotubes (Q23909988) (← links)
- Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas (Q24299520) (← links)
- Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling (Q24313188) (← links)
- Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-beta signaling (Q24321772) (← links)
- C18 ORF1, a novel negative regulator of transforming growth factor-β signaling (Q24339143) (← links)
- miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells (Q24613084) (← links)
- Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer (Q24625197) (← links)
- Matrix crosslinking forces tumor progression by enhancing integrin signaling (Q24646370) (← links)
- Preclinical efficacy of cystatin C to target the oncogenic activity of transforming growth factor Beta in breast cancer (Q24648403) (← links)
- The basics of epithelial-mesenchymal transition (Q24652992) (← links)
- High-level inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix composition (Q24683692) (← links)
- Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling (Q24685123) (← links)
- Molecular therapeutics in pancreas cancer (Q26751709) (← links)
- Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions (Q26771696) (← links)
- Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives (Q26779725) (← links)
- Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites (Q26798402) (← links)
- The role of microenvironment and immunity in drug response in leukemia (Q26800735) (← links)
- Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not Destruction (Q26801834) (← links)
- Vaccines for pancreatic cancer (Q26825850) (← links)
- Epithelial mesenchymal transition from a natural gestational orchestration to a bizarre cancer disturbance (Q26826431) (← links)
- Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies (Q26849553) (← links)
- Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention (Q26850218) (← links)
- Transcriptional control of cancer metastasis (Q26992024) (← links)
- The role of the myofibroblast in tumor stroma remodeling (Q26997815) (← links)
- Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer (Q27021391) (← links)
- MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives (Q27022292) (← links)
- Oligomeric interactions of TGF-β and BMP receptors (Q27023170) (← links)
- TGF-β - an excellent servant but a bad master (Q27025590) (← links)
- A photoactivatable nanopatterned substrate for analyzing collective cell migration with precisely tuned cell-extracellular matrix ligand interactions (Q27315606) (← links)
- Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer (Q27331671) (← links)
- TGFΒ-induced transcription in cancer (Q28075605) (← links)
- TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression (Q28076815) (← links)
- The tumor microenvironment in esophageal cancer (Q28077074) (← links)
- Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies (Q28079488) (← links)
- Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment (Q28080529) (← links)
- Role of TGFβ in regulation of the tumor microenvironment and drug delivery (review) (Q28081170) (← links)
- TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis (Q28083107) (← links)
- Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization (Q28118751) (← links)
- Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells (Q28237286) (← links)
- The role of p21 in regulating mammalian regeneration (Q28242137) (← links)
- Posttranscriptional regulation of cancer traits by HuR (Q28248667) (← links)
- TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4 (Q28275478) (← links)
- Mediator MED15 modulates transforming growth factor beta (TGFβ)/Smad signaling and breast cancer cell metastasis (Q28275811) (← links)
- Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion (Q28280615) (← links)
- TGFbeta in Cancer (Q28288866) (← links)
- The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors (Q28295428) (← links)
- Role of mitogen-activated protein kinase kinase 4 in cancer (Q28301942) (← links)